These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Clinical findings, pathology, and outcomes of C3GN after kidney transplantation. Zand L; Lorenz EC; Cosio FG; Fervenza FC; Nasr SH; Gandhi MJ; Smith RJ; Sethi S J Am Soc Nephrol; 2014 May; 25(5):1110-7. PubMed ID: 24357668 [TBL] [Abstract][Full Text] [Related]
23. Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits is associated with high rate of early recurrence in the allograft. Said SM; Cosio FG; Valeri AM; Leung N; Sethi S; Salameh H; Cornell LD; Fidler ME; Alexander MP; Fervenza FC; Drosou ME; Zhang D; D'Agati VD; Nasr SH Kidney Int; 2018 Jul; 94(1):159-169. PubMed ID: 29716794 [TBL] [Abstract][Full Text] [Related]
24. Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk. Little MA; Dupont P; Campbell E; Dorman A; Walshe JJ Kidney Int; 2006 Feb; 69(3):504-11. PubMed ID: 16395262 [TBL] [Abstract][Full Text] [Related]
25. Plasmapheresis maintained renal function in an allograft with recurrent membranoproliferative glomerulonephritis type I. Muczynski KA Am J Nephrol; 1995; 15(5):446-9. PubMed ID: 7503148 [TBL] [Abstract][Full Text] [Related]
26. Immunohistological and ultrastructural differences between recurrent type I membranoproliferative glomerulonephritis and chronic transplant glomerulopathy. Andresdottir MB; Assmann KJ; Koene RA; Wetzels JF Am J Kidney Dis; 1998 Oct; 32(4):582-8. PubMed ID: 9774118 [TBL] [Abstract][Full Text] [Related]
27. Clinicopathological analysis of proliferative glomerulonephritis with monoclonal IgG deposits in 5 renal allografts. Wen J; Wang W; Xu F; Chen J; Zhang M; Cheng D; Ni X; Li X; Liu Z BMC Nephrol; 2018 Jul; 19(1):173. PubMed ID: 29996809 [TBL] [Abstract][Full Text] [Related]
28. Renal Pathologic Findings in TAFRO Syndrome: Is There a Continuum Between Thrombotic Microangiopathy and Membranoproliferative Glomerulonephritis? A Case Report and Literature Review. Leurs A; Gnemmi V; Lionet A; Renaud L; Gibier JB; Copin MC; Hachulla E; Hatron PY; Launay D; Fajgenbaum D; Terriou L Front Immunol; 2019; 10():1489. PubMed ID: 31316523 [No Abstract] [Full Text] [Related]
29. De novo proliferative glomerulonephritis with monoclonal IgG deposits of the IgG1κ subtype in a kidney allograft. Tsuji T; Miura M; Yanai M; Itami H; Ishii Y; Akimoto M; Fukasawa Y Nephrology (Carlton); 2016 Jul; 21 Suppl 1():44-7. PubMed ID: 26976360 [TBL] [Abstract][Full Text] [Related]
30. Renal transplantation in patients with dense deposit disease: morphological characteristics of recurrent disease and clinical outcome. Andresdottir MB; Assmann KJ; Hoitsma AJ; Koene RA; Wetzels JF Nephrol Dial Transplant; 1999 Jul; 14(7):1723-31. PubMed ID: 10435883 [TBL] [Abstract][Full Text] [Related]
31. Recurrence of type I membranoproliferative glomerulonephritis after renal transplantation: analysis of the incidence, risk factors, and impact on graft survival. Andresdottir MB; Assmann KJ; Hoitsma AJ; Koene RA; Wetzels JF Transplantation; 1997 Jun; 63(11):1628-33. PubMed ID: 9197358 [TBL] [Abstract][Full Text] [Related]
33. Treatment-resistant recurrent membranoproliferative glomerulonephritis in renal allograft responding to rituximab: case report. Farooqui M; Alsaad K; Aloudah N; Alhamdan H Transplant Proc; 2015 Apr; 47(3):823-6. PubMed ID: 25891740 [TBL] [Abstract][Full Text] [Related]
34. Long-term clinical and morphological evaluation of primary membranoproliferative glomerulonephritis. Wu MJ; Shu KH; Chan LP; Lu YS; Cheng CH; Sheu SS; Hsu YH; Lian JD Zhonghua Yi Xue Za Zhi (Taipei); 1996 Jan; 57(1):34-41. PubMed ID: 8820034 [TBL] [Abstract][Full Text] [Related]
35. Glomerular paramesangial deposits: association with hypocomplementemia in membranoproliferative glomerulonephritis types I and III. West CD; McAdams AJ Am J Kidney Dis; 1998 Mar; 31(3):427-34. PubMed ID: 9506679 [TBL] [Abstract][Full Text] [Related]
37. Treatment of acute antibody-mediated rejection using bortezomib: a case report. Sin YH; Kim YJ; Oh JS; Lee JH; Kim SM; Kim JK Nephrology (Carlton); 2015 Jul; 20 Suppl 2():86-9. PubMed ID: 26031595 [TBL] [Abstract][Full Text] [Related]
38. Membranoproliferative glomerulonephritis with masked monotypic immunoglobulin deposits. Larsen CP; Messias NC; Walker PD; Fidler ME; Cornell LD; Hernandez LH; Alexander MP; Sethi S; Nasr SH Kidney Int; 2015 Oct; 88(4):867-73. PubMed ID: 26154922 [TBL] [Abstract][Full Text] [Related]
39. Allograft failure in kidney transplant recipients with membranoproliferative glomerulonephritis. Angelo JR; Bell CS; Braun MC Am J Kidney Dis; 2011 Feb; 57(2):291-9. PubMed ID: 21215503 [TBL] [Abstract][Full Text] [Related]
40. Outcome of primary glomerular disease in pediatric renal transplantation: a single-center experience. Bilginer Y; Topaloglu R; Aki FT; Demirkaya E; Ozaltin F; Besbas N; Ozen S; Bakkaloglu A; Erkan I; Bakkaloglu M Transplant Proc; 2008; 40(1):129-31. PubMed ID: 18261566 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]